U.K. Watchdog U-Turns On AstraZeneca: Says Under 30s Should Take Alternative Covid-19 Vaccine

Topline

The U.K.’s medicines regulator has said under 30s should be offered an alternative vaccine to AstraZeneca’s Covid-19 shot Wednesday after finding a possible link between it and a rare, potentially lethal form of blood clotting, an abrupt course correction that could complicate the country’s strong immunization program and yet another knock to the AstraZeneca shot, which has suffered numerous setbacks around the world.  

Key Facts

The Medicines and Healthcare Products Regulatory Agency (MHRA) said it had established a potential link between a rare type of blood clotting and the AstraZeneca shot after studying reports of 79 people suffering clots after vaccination by the end of March.

The regulator’s findings echoed those of the European Medicines Agency’s (EMA), which were also released Wednesday. 

Unlike the EMA, which recommended the clotting be added to the list of side effects but did not make a significant policy

Keep reading this article on Forbes Business.

Leave a Reply